Concepts (123)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urban Population | 3 | 2025 | 201 | 0.440 |
Why?
|
| Vagina | 2 | 2025 | 87 | 0.380 |
Why?
|
| Intellectual Disability | 1 | 2025 | 177 | 0.370 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 186 | 0.330 |
Why?
|
| Kidney Transplantation | 2 | 2024 | 326 | 0.330 |
Why?
|
| Cervix Uteri | 2 | 2025 | 58 | 0.300 |
Why?
|
| Time-to-Treatment | 3 | 2024 | 133 | 0.280 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 712 | 0.240 |
Why?
|
| Vaginosis, Bacterial | 2 | 2025 | 15 | 0.230 |
Why?
|
| Chlamydia trachomatis | 1 | 2025 | 60 | 0.210 |
Why?
|
| Metabolic Diseases | 1 | 2025 | 60 | 0.210 |
Why?
|
| Laryngeal Neoplasms | 1 | 2024 | 49 | 0.210 |
Why?
|
| Chlamydia Infections | 1 | 2025 | 79 | 0.210 |
Why?
|
| Microbiota | 2 | 2025 | 171 | 0.210 |
Why?
|
| Trichomonas Vaginitis | 1 | 2023 | 7 | 0.200 |
Why?
|
| Cost of Illness | 1 | 2025 | 169 | 0.200 |
Why?
|
| Trichomonas vaginalis | 1 | 2023 | 9 | 0.200 |
Why?
|
| Food | 1 | 2024 | 76 | 0.200 |
Why?
|
| Acidosis | 1 | 2023 | 28 | 0.190 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2023 | 42 | 0.190 |
Why?
|
| Poverty | 1 | 2025 | 307 | 0.190 |
Why?
|
| Spouse Abuse | 1 | 2023 | 44 | 0.190 |
Why?
|
| Acute Kidney Injury | 1 | 2024 | 143 | 0.180 |
Why?
|
| Health Literacy | 1 | 2023 | 95 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 378 | 0.180 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 264 | 0.180 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 150 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 166 | 0.170 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 154 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 97 | 0.170 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 146 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2025 | 1148 | 0.170 |
Why?
|
| Patient-Centered Care | 1 | 2024 | 268 | 0.170 |
Why?
|
| Child, Preschool | 4 | 2025 | 2089 | 0.160 |
Why?
|
| Female | 15 | 2025 | 34424 | 0.160 |
Why?
|
| Hypersensitivity | 1 | 2021 | 73 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 134 | 0.160 |
Why?
|
| Humans | 21 | 2025 | 65843 | 0.150 |
Why?
|
| India | 2 | 2025 | 165 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 354 | 0.150 |
Why?
|
| Adolescent | 7 | 2025 | 6368 | 0.150 |
Why?
|
| Hypertension | 1 | 2024 | 618 | 0.140 |
Why?
|
| Child | 5 | 2025 | 4652 | 0.140 |
Why?
|
| Depression | 1 | 2025 | 910 | 0.130 |
Why?
|
| Telemedicine | 1 | 2023 | 379 | 0.130 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 94 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 878 | 0.130 |
Why?
|
| Cervix Mucus | 1 | 2016 | 1 | 0.120 |
Why?
|
| Mouth | 1 | 2016 | 36 | 0.120 |
Why?
|
| Neoplasms | 2 | 2024 | 1378 | 0.120 |
Why?
|
| Risk Factors | 5 | 2025 | 5475 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2023 | 922 | 0.120 |
Why?
|
| Anal Canal | 1 | 2016 | 38 | 0.120 |
Why?
|
| Asthma | 1 | 2021 | 489 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2018 | 370 | 0.110 |
Why?
|
| Prevalence | 3 | 2025 | 1454 | 0.110 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 2739 | 0.110 |
Why?
|
| Heart Failure | 1 | 2023 | 968 | 0.110 |
Why?
|
| Male | 9 | 2025 | 31410 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 417 | 0.110 |
Why?
|
| Pakistan | 2 | 2025 | 15 | 0.110 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 1235 | 0.100 |
Why?
|
| Liver | 1 | 2018 | 875 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2024 | 6957 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2012 | 11 | 0.090 |
Why?
|
| Metagenome | 1 | 2012 | 18 | 0.090 |
Why?
|
| Young Adult | 4 | 2025 | 4883 | 0.090 |
Why?
|
| Aged | 5 | 2025 | 15147 | 0.080 |
Why?
|
| Infant | 1 | 2025 | 1717 | 0.080 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2025 | 107 | 0.070 |
Why?
|
| Middle Aged | 5 | 2025 | 18501 | 0.070 |
Why?
|
| Adult | 5 | 2025 | 17579 | 0.070 |
Why?
|
| Biomarkers | 2 | 2024 | 1503 | 0.060 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2025 | 25 | 0.050 |
Why?
|
| Cystatin C | 1 | 2024 | 9 | 0.050 |
Why?
|
| Radioimmunotherapy | 1 | 2023 | 7 | 0.050 |
Why?
|
| Chemoradiotherapy | 1 | 2024 | 75 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2024 | 72 | 0.050 |
Why?
|
| Creatinine | 1 | 2024 | 136 | 0.050 |
Why?
|
| Alkalies | 1 | 2023 | 4 | 0.050 |
Why?
|
| Bicarbonates | 1 | 2023 | 17 | 0.050 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2023 | 25 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 122 | 0.050 |
Why?
|
| Transplant Recipients | 1 | 2023 | 32 | 0.050 |
Why?
|
| B7-H1 Antigen | 1 | 2023 | 60 | 0.050 |
Why?
|
| Physical Abuse | 1 | 2023 | 4 | 0.050 |
Why?
|
| Electronics | 1 | 2023 | 34 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2024 | 579 | 0.050 |
Why?
|
| Community Health Services | 1 | 2024 | 127 | 0.050 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 108 | 0.050 |
Why?
|
| Molecular Medicine | 1 | 2022 | 2 | 0.040 |
Why?
|
| Survival Rate | 1 | 2024 | 849 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2023 | 253 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2023 | 514 | 0.040 |
Why?
|
| Metagenomics | 1 | 2022 | 29 | 0.040 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 19 | 0.040 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2021 | 6 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 21 | 0.040 |
Why?
|
| Desensitization, Immunologic | 1 | 2021 | 13 | 0.040 |
Why?
|
| Allergens | 1 | 2021 | 54 | 0.040 |
Why?
|
| New York | 1 | 2021 | 144 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2022 | 274 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1294 | 0.040 |
Why?
|
| Hospitals | 1 | 2023 | 399 | 0.040 |
Why?
|
| Quality Improvement | 1 | 2024 | 473 | 0.040 |
Why?
|
| Internet | 1 | 2023 | 472 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 46 | 0.040 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 28 | 0.040 |
Why?
|
| Bacteria | 1 | 2022 | 337 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2024 | 726 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 2651 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 965 | 0.030 |
Why?
|
| Biopsy | 1 | 2018 | 463 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2018 | 129 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2018 | 491 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 2790 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 369 | 0.030 |
Why?
|
| Diet | 1 | 2018 | 540 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 1569 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 1266 | 0.020 |
Why?
|
| RNA, Bacterial | 1 | 2012 | 73 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 267 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 316 | 0.020 |
Why?
|